期刊
CELLS
卷 10, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/cells10123379
关键词
methylene blue; mitochondria; neurodegeneration; skin aging; progeria
类别
资金
- NIH [R01HL126784]
Methylene blue, the first fully man-made medicine, has a wide range of clinical applications and its anti-oxidative properties have brought new attention to this century-old drug. It can bypass Complex I/III activity in mitochondria and diminish oxidative stress to some degree, making it applicable for treating age-related conditions.
Methylene blue (MB), as the first fully man-made medicine, has a wide range of clinical applications. Apart from its well-known applications in surgical staining, malaria, and methemoglobinemia, the anti-oxidative properties of MB recently brought new attention to this century-old drug. Mitochondrial dysfunction has been observed in systematic aging that affects many different tissues, including the brain and skin. This leads to increaseding oxidative stress and results in downstream phenotypes under age-related conditions. MB can bypass Complex I/III activity in mitochondria and diminish oxidative stress to some degree. This review summarizes the recent studies on the applications of MB in treating age-related conditions, including neurodegeneration, memory loss, skin aging, and a premature aging disease, progeria.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据